Greg Furrow
Technik-/Wissenschafts-/F&E-Leiter bei MUSTANG BIO, INC.
Ursprung des Netzwerks ersten Grades von Greg Furrow
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 | |
Southern Research Institute
 Southern Research Institute Miscellaneous Commercial ServicesCommercial Services Southern Research Institute is a scientific research organization. It focuses on research in drug discovery, drug development, energy and environment, and engineering. The firm serves pharmaceutical, biotechnology, defense, aerospace, environmental, and energy industries The company was founded in 1941 and is headquartered in Birmingham, AL.
4
| Non-Profit Organization | Miscellaneous Commercial Services | 4 |
Charles River Laboratories Ashland LLC
 Charles River Laboratories Ashland LLC Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories Ashland LLC provides product safety and toxicological assessment research and services. It serves the international pharmaceutical, biotechnology, chemical, agricultural, veterinary, food, and consumer products industries. The firm's services include toxicology, discovery, ADME & DMPK, analytical and regulatory services, safety pharmacology, and pathology. The company was founded in 1976 and is headquartered in Ashland, OH.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Greg Furrow
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer Director/Board Member | |
| NATIONAL HOLDINGS CORPORATION | Investment Banks/Brokers | Chairman Director/Board Member | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| BRAINSTORM CELL THERAPEUTICS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
WIL Research Holding Co., Inc.
 WIL Research Holding Co., Inc. Miscellaneous Commercial ServicesCommercial Services WIL Research Holding Co., Inc. provides product safety toxicological research, bio analytical chemistry and formulation services. The company was founded in September 2004 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| AQUESTIVE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Comptroller/Controller/Auditor | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Chief Executive Officer | |
| Texas Tech University | College/University | Undergraduate Degree | |
| The University of Alabama | College/University | Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| Roosevelt University | College/University | Masters Business Admin | |
| University of Florida | College/University | Undergraduate Degree | |
| Yeshiva University | College/University | Undergraduate Degree Undergraduate Degree | |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Chief Executive Officer Founder | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
Baptist Homes, Inc.
 Baptist Homes, Inc. Hospital/Nursing ManagementHealth Services Baptist Homes, Inc. offers therapy, rehabilitation and nursing care services. It also provides residences, heallthcare and senior living services. The company was founded by James Bernard Lewis in 1966 and is headquartered in Louisville, KY. | Hospital/Nursing Management | Director/Board Member | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
| Columbia Law School | College/University | Graduate Degree Graduate Degree | |
| American Brachytherapy Society | President | ||
Amerigen Pharmaceuticals Ltd.
 Amerigen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Amerigen Pharmaceuticals Ltd. engages in the development, manufacturing, and sale of generic pharmaceutical products. The company was founded in 2007 and is headquartered in Lyndhurst, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| Yale School of Medicine | College/University | Doctorate Degree | |
| New York University School of Law | College/University | Graduate Degree | |
| The University of Alabama School of Law | College/University | Graduate Degree | |
| ORIGO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer Chairman Director/Board Member Director/Board Member | |
| CHECKPOINT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Investor Relations Contact | |
| AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Investor Relations Contact | |
Helocyte, Inc.
 Helocyte, Inc. Miscellaneous Commercial ServicesCommercial Services Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Wejo Ltd.
 Wejo Ltd. Packaged SoftwareTechnology Services Wejo Ltd. develops smart phone applications that monitor driving behavior and displays driving scores. It specializes in car insurance comparison, fleet management solutions, mobile app development and data management. The company was founded by Richard Barlow in 2013 and is headquartered in Cheshire, the United Kingdom. | Packaged Software | Director of Finance/CFO | |
| CONVATEC GROUP PLC | Medical Specialties | Corporate Officer/Principal | |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortress Biotech, Inc., Cyprium Therapeutics, Inc. is an American New York-based company focused on developing novel therapies for the treatment of Menkes disease and related copper metabolism disorders. The company was granted FDA breakthrough therapy, fast track, and rare pediatric disease designations, as well as FDA orphan drug designation for both Cutx-101 and AAV-ATP7A. The European Medicines Agency also granted orphan drug designation to Cyprium. In March 2017, Cyprium entered into a cooperative research and development agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development to advance the clinical development of Cutx-101 for the treatment of Menkes disease. In 2023, Cyprium completed the transfer of its proprietary rights and assigned its FDA documents pertaining to Cutx-101 to Sentynl Therapeutics, Inc. Cyprium and NICHD also previously entered into a worldwide, exclusive license agreement to develop and commercialize AAV-ATP7A gene therapy, which is currently in pre-clinical development. The company was founded in 2017 by Michael Sean Weiss, Lindsay Allan Rosenwald, and Lung S. Yam, who has been the CEO since then. | Miscellaneous Commercial Services | Founder Founder | |
| Cellvation, Inc. | Chairman Director/Board Member | ||
| JOURNEY MEDICAL CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member Investor Relations Contact | |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | General Counsel | |
On Demand Pharmaceuticals, Inc.
 On Demand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology On Demand Pharmaceuticals, Inc. is an innovative technology company that is transforming the way medicines are made. On Demand Pharmaceuticals is based in Richmond, VA and was founded by Shiu Fei Ling. The private company's breakthrough manufacturing technology platform, the Pharmacy on Demand (POD), allows for the production of medicines on demand, wherever and whenever they are needed. The company's mission is to provide an adequate, safe, and reliable supply of medicines to every community worldwide. | Pharmaceuticals: Major | Director of Finance/CFO | |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| WEJO GROUP LIMITED | Packaged Software | President | |
| Yellowstone Merger Sub, Inc. | President | ||
| Wejo Bermuda Ltd. | President | ||
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO |
Statistik
International
| Vereinigte Staaten | 45 |
| Vereinigtes Königreich | 5 |
| Schweiz | 2 |
| Bermuda | 2 |
Sektoral
| Health Technology | 20 |
| Consumer Services | 14 |
| Finance | 5 |
| Commercial Services | 5 |
| Communications | 3 |
Operativ
| Director/Board Member | 47 |
| Corporate Officer/Principal | 39 |
| Director of Finance/CFO | 28 |
| Chairman | 23 |
| Undergraduate Degree | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Michael Weiss | 25 |
| Lindsay Rosenwald | 23 |
| Neil Herskowitz | 22 |
| Eliot Lurier | 13 |
| John Maxwell | 12 |
| Adam Chill | 11 |
| James Murphy | 8 |
| Sadik Kassim | 8 |
| Brian Achenbach | 8 |
| Susan E. Ward | 7 |
| William Grieco | 7 |
| Michael Zelefsky | 6 |
| Manuel Litchman | 6 |
| Martina A. Sersch | 5 |
| Lynn E. Bayless | 5 |
- Börse
- Insiders
- Greg Furrow
- Unternehmensverbindungen
